Price to Sales ratio Analysis of Pliant Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PS
Period Ending - Dec-23
Very Poor PS
200920
Period Ending - Dec-22
Very Poor PS
52.62
Growth
381711 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
70336.28
PS Analysis of Pliant Therapeutics Inc
| P/S Ratio of Pliant Therapeutics Inc with value of 70336.28 indicates that stock price is high compared to sales of the company and may be overvalued. |
| PS Ratio of PLRX rose handsomely by 381711 % this year. |
| PS Ratio with value of 200920 was highest in Year Dec-23 in last Five Years. |
| PS Ratio with value of 3.51 was lowest in Year Dec-19 in last Five Years. |
| Latest PS Ratio with value of 200920 is Greater than Average PS of 40208.01 in last five years. |
Other PS Related Info of PLRX that may interest you.
Pliant Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| PLRX | 12.13 | 12.17 | 0.329 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..
PS Related Ratios
| PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Price to Sales of Pliant Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| PS | 200920 | 52.62 | 57.42 | 6.19 | 3.51 | 0 | 0 |
| Change | 381711 % | -8.36 % | 827.49 % | 76.38 % |
FY Chart of Price to Sales of Pliant Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)